Introduction: Insulinomas are rare functional and benign neuroendocrine tumors of Pancreas.
Aim(s): We aim to find the current best practices for the diagnosis and management of Insulinoma.
Materials and methods: A retrospective study and 104 patients diagnosed with Insulinoma were included in the study. The diagnosis was confirmed by identifying common symptoms such as hypoglycemia, dizziness, behavioural changes, tachycardia and diaphoresis. The 48-hour test, performed by measuring blood glucose levels of insulin, C peptide, and proinsulin collected every 4–6 hours in fasting patients, accurately confirmed the diagnosis of insulinoma in the majority of the patients. A multiphase CT was used to identify the location of lesion and well as metastasis. In 15 patients, arterial calcium stimulation test was used to identify the lesion region in pancreas.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Medical treatment - Targeted therapies
Presenting Author: Dr Arooj Fatima
To read results and conclusion, please login ...
Further abstracts you may be interested in